Moderna (MRNA)

Other Income/Expenses (Net)

$233.00M

TTM · Period ending: · USD

MRNA logo

MRNA Other Income/Expenses (Net)

Latest reported$233.00M
MRNA TTM Other Income/Expenses (Net) ($13.36M → $233.00M)
High-resolution chart · PNG

MRNA other income/expenses (net) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Moderna Other Income/Expenses (Net) — Trailing twelve months (TTM) (USD)
Period endingOther Income/Expenses (Net) (USD)
233,000,000
274,000,000
306,000,000
310,000,000
328,000,000
323,000,000
338,000,000
340,000,000
303,000,000
337,000,000
297,000,000
308,000,000
305,000,000
214,000,000
155,000,000
80,000,000
23,000,000
-3,000,000
-11,000,000
-6,974,000
1,371,000
5,933,000
18,631,000
21,702,000
26,728,000
29,611,000
31,954,000
36,630,000
34,746,000
32,873,000
28,858,000
20,798,000
18,396,000
15,105,000
13,360,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.